Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karoly Toth

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Translational Oncology|August 25, 2009
Acute vascular disruption by 5,6-dimethylxanthenone-4-acetic Acid in an orthotopic model of human head and neck cancerMukund Seshadri, Karoly Toth
Current Gene Therapy|November 28, 2013
Adenovirus vectors for gene therapy, vaccination and cancer gene therapyWilliam S M Wold, Karoly Toth
Viruses|October 14, 2011
Increasing the efficacy of oncolytic adenovirus vectorsKaroly Toth, William S M Wold
Advances in Cancer Research|October 2, 2012
Chapter three--Syrian hamster as an animal model to study oncolytic adenoviruses and to evaluate the efficacy of antiviral compoundsWilliam S M Wold, Karoly Toth
Expert Opinion on Pharmacotherapy|September 3, 2015
New drug on the horizon for treating adenovirusWilliam S M Wold, Karoly Toth
Methods in Molecular Biology (Clifton, N.J.)|September 28, 2011
Syrian hamster tumor model to study oncolytic Ad5-based vectorsDebanjan Dhar, Karoly Toth, William S M Wold
Expert Opinion on Biological Therapy|February 6, 2010
Oncolytic (replication-competent) adenoviruses as anticancer agentsKaroly Toth, Debanjan Dhar, William S M Wold
Methods in Molecular Medicine|April 3, 2007
Immunocompetent, semi-permissive cotton rat tumor model for the evaluation of oncolytic adenovirusesKaroly Toth, Jacqueline F Spencer, William S M Wold
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 11, 2010
Double immunohistochemical staining method for HIF-1alpha and its regulators PHD2 and PHD3 in formalin-fixed paraffin-embedded tissuesMary M Vaughan, Karoly Toth, Sreenivasulu Chintala, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2009
Pre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster modelDebanjan Dhar, Jacqueline F Spencer, Karoly Toth, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Translational Oncology|August 25, 2009
Acute vascular disruption by 5,6-dimethylxanthenone-4-acetic Acid in an orthotopic model of human head and neck cancerMukund Seshadri, Karoly Toth
Current Gene Therapy|November 28, 2013
Adenovirus vectors for gene therapy, vaccination and cancer gene therapyWilliam S M Wold, Karoly Toth
Viruses|October 14, 2011
Increasing the efficacy of oncolytic adenovirus vectorsKaroly Toth, William S M Wold
Advances in Cancer Research|October 2, 2012
Chapter three--Syrian hamster as an animal model to study oncolytic adenoviruses and to evaluate the efficacy of antiviral compoundsWilliam S M Wold, Karoly Toth
Expert Opinion on Pharmacotherapy|September 3, 2015
New drug on the horizon for treating adenovirusWilliam S M Wold, Karoly Toth
Methods in Molecular Biology (Clifton, N.J.)|September 28, 2011
Syrian hamster tumor model to study oncolytic Ad5-based vectorsDebanjan Dhar, Karoly Toth, William S M Wold
Expert Opinion on Biological Therapy|February 6, 2010
Oncolytic (replication-competent) adenoviruses as anticancer agentsKaroly Toth, Debanjan Dhar, William S M Wold
Methods in Molecular Medicine|April 3, 2007
Immunocompetent, semi-permissive cotton rat tumor model for the evaluation of oncolytic adenovirusesKaroly Toth, Jacqueline F Spencer, William S M Wold
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 11, 2010
Double immunohistochemical staining method for HIF-1alpha and its regulators PHD2 and PHD3 in formalin-fixed paraffin-embedded tissuesMary M Vaughan, Karoly Toth, Sreenivasulu Chintala, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2009
Pre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster modelDebanjan Dhar, Jacqueline F Spencer, Karoly Toth, et al.
Pageof 7